In serous ovarian cancer patients, OSF-2 expression was significantly higher in metastasis than in primary tumors [30], whilst in another ovarian cancer study, OSF-2 expression was correlated with disease progression and promotion of cancer angiogenesis and metastasis [31]. This evidence concerns the gene POSTN and ovarian serous adenocarcinoma.